Marcus Hui

G.I. Windows, Inc. develops and markets a technology which involves a series of self assembling magnets (SAMSEN) for incision less bypass procedures within the digestive system. It specializes in non-surgical bypass and nitial clinical applications. The company was founded by Christopher Thompson and Marvin Ryou and is headquartered in West Bridgewater, MA.

Peking University provides post-secondary education services. It offers undergraduate and graduate courses. It provides courses such as basic and applied sciences, social sciences and the humanities, sciences of medicine, management, and education. The company was founded by JiaNai Sun in 1898 and is headquartered in Beijing, China.

Delos Capital LLC (Delos Capital) is a private equity firm founded in 2013 by Mattew Constantino. The firm is headquartered in New York.

Oxford Investment Consultants LLP (Oxford Investment Consultants) is a venture capital firm founded in 2015 by George Edward Silvanus Robinson and Ross Hyett. The firm is headquartered in Oxford, London.

Beijing All View Cloud Data Technology Co. Ltd. (Research) is the research division of Beijing All View Cloud Data Technology Co. Ltd. (OC: 831101) in China. Established in 2011, the firm is headquartered in Beijing and provides data research to their parent firm.

Cellular Biomedicine Group (Shanghai) Ltd. engages in development and sales of laboratory equipment and consumables, biological reagents. The company was founded on October 19, 2011 and is headquartered in Shanghai, China.

Beijing All View Cloud Data Technology Co., Ltd. principally engages in the provision of technical and operation services of big data for enterprises and users in the field of smart home. It offers comprehensive big data solutions and product lines, such as home appliance sales data, display industry chain data, real estate and home data, as well as over-the-top data. The company was founded on September 2007 and is headquartered in Beijing, China.

I-Mab Biopharma (Shanghai) Co., Ltd. engages in the development of biologics. It focuses on monoclonal antibodies or bi-specific antibodies in the areas of immuno-oncology and autoimmune diseases. The company was founded by Jingwu Zang in March 2017 and is headquartered in Shanghai, China.